Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4740-4744

  Fiebelkorn, K R ^a,b   Crawford, S A ^a   McElmeel, M L ^a   Jorgensen, J H ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ERMA GENE; ERMC GENE; MSRA GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; COAGULASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0141958253     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4740-4744.2003     Document Type: Article

References (24)

1. Catchpole, I., and K. G. H. Dyke. 1990. A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator. FEMS Microbiol. Lett. 69:43-48.
2. Di Modugno, V., M. Guerrini, S. Shah, and J. Hamilton-Miller. 2002. Low level resistance to oleandomycin as a marker of ermA in staphylococci. J. Antimicrob. Chemother. 49:423-430.
3. Drinkovic, D., E. R. Fuller, K. P. Shore, D. J. Holland, and R. Ellis-Pegler. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316.
4. Eady, E. A., J. I. Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble. 1993. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31:211-217.
5. Frank, A. L., J. F. Marcinak, P. D. Mahgat, J. T. Tjhio, S. Kelkar, P. C. Schreckenberger, and J. P. Quinn. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534.
6. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin, and M. P. Weinstein. 1987. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888.
7. Kasten, M. J. 1999. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin. Proc. 74:825-833.
8. Khan, S. A., M. S. Nawaz, A. A. Khan, and C. E. Cerniglia. 1999. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. Mol. Cell. Probes 13:381-387.
9. Ligozzi, M., C. Bernini, M. G. Bonora, M. de Fatima, J. Zuliani, and R. Fontana. 2002. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J. Clin. Microbiol. 40:1681-1686.
10. Lina, G., A. Quaglia, M. E. Reverdy, R. Leclercq, F. Vandenesch, and J. Etienne. 1999. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob. Agents Chemother. 43:1062-1066.
11. McGehee, R. F., F. F. Barrett, and F. Finland. 1969. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. Antimicrob. Agents Chemother. 1968:392-397.
12. NCCLS. 2003. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. NCCLS, Wayne, Pa.
13. Nicola, F. G., L. K. McDougal, J. W. Biddle, and F. C. Tenover. 1998. Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969. Antimicrob. Agents Chemother. 42:3024-3027.
14. Panagea, S., J. D. Perry, and F. K. Gould. 1999. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J. Antimicrob. Chemother. 44:581-582.
15. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
16. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
17. Ross, J. I., A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1989. Characterisation and molecular cloning of the novel macrolide-strepto-gramin B resistance determinant from Staphylococcus epidermidis. J. Antimicrob. Chemother. 24:851-862.
18. Sanchez, M. L., K. K. Flint, and R. N. Jones. 1993. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Diagn. Microbiol. Infect. Dis. 16:205-213.
19. Schmitz, F. J., J. Petridou, A. C. Fluit, U. Hadding, G. Peters, and C. von Eiff. 2000. Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 19:385-387.
20. Thakker-Varia, S., W. D. Jenssen, L. Moon-McDermott, M. P. Weinstein, and D. T. Dubin. 1987. Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob. Agents Chemother. 31:735-743.
21. Tuazon, C. U., and J. N. Sheagren. 1975. Relapse of staphylococcal endocarditis after clindamycin therapy. Am. J. Med. Sci. 269:145-148.
22. Watanakunakorn, C. 1976. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am. J. Med. 60:419-425.
23. Weisblum, B., and V. Demohn. 1969. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J. Bacteriol. 98:447-452.
24. Werckenthin, C., S. Schwarz, and H. Westh. 1999. Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob, Agents Chemother. 43:1681-1685.